NO963987L - Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske aminoacetylmercaptoderivater - Google Patents

Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske aminoacetylmercaptoderivater

Info

Publication number
NO963987L
NO963987L NO963987A NO963987A NO963987L NO 963987 L NO963987 L NO 963987L NO 963987 A NO963987 A NO 963987A NO 963987 A NO963987 A NO 963987A NO 963987 L NO963987 L NO 963987L
Authority
NO
Norway
Prior art keywords
aminoacetylmercapto
derivatives
hypotriglyceridemic
antiatherosclerotic
hypocholesterolemic
Prior art date
Application number
NO963987A
Other languages
English (en)
Norwegian (no)
Other versions
NO963987D0 (no
Inventor
Gary Alan Flynn
John Fitzhugh French
Richard Cyrus Dage
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO963987D0 publication Critical patent/NO963987D0/no
Publication of NO963987L publication Critical patent/NO963987L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO963987A 1994-03-24 1996-09-23 Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske aminoacetylmercaptoderivater NO963987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21735094A 1994-03-24 1994-03-24
PCT/US1995/002458 WO1995025532A1 (en) 1994-03-24 1995-02-28 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives

Publications (2)

Publication Number Publication Date
NO963987D0 NO963987D0 (no) 1996-09-23
NO963987L true NO963987L (no) 1996-11-22

Family

ID=22810704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963987A NO963987L (no) 1994-03-24 1996-09-23 Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske aminoacetylmercaptoderivater

Country Status (19)

Country Link
US (2) US5624921A (de)
EP (1) EP0751783B1 (de)
JP (1) JPH09510476A (de)
CN (1) CN1144487A (de)
AT (1) ATE189392T1 (de)
AU (1) AU698320B2 (de)
CA (1) CA2184696C (de)
DE (1) DE69514912T2 (de)
DK (1) DK0751783T3 (de)
ES (1) ES2141923T3 (de)
FI (1) FI963783L (de)
GR (1) GR3033117T3 (de)
HU (1) HUT75160A (de)
IL (1) IL113076A (de)
NO (1) NO963987L (de)
NZ (1) NZ282568A (de)
PT (1) PT751783E (de)
WO (1) WO1995025532A1 (de)
ZA (1) ZA952284B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
DE602004023100D1 (de) * 2003-10-08 2009-10-22 Lilly Co Eli Verbindungen und verfahren zur behandlung von dyslipidemie

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (de) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazin-Derivate, Zwischenprodukte und Verfahren zu deren Herstellung, sowie diese enthaltende Arzneimittel
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
NZ204130A (en) * 1982-05-12 1986-03-14 Hoffmann La Roche Bicyclic heterocyclic compounds and pharmaceutical compositions
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
ATE60605T1 (de) * 1985-04-30 1991-02-15 Lilly Co Eli 7-substituierte bicyclische pyrazolidinone.
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
ZA874107B (de) * 1986-06-13 1987-12-09
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
WO1991009840A1 (en) * 1989-12-22 1991-07-11 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
FR2659332B1 (fr) * 1990-03-08 1994-04-29 Adit Et Cie Nouvelles pyrrolo [1,2-a] thieno [3,2-f] diazepines [1,4], leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0492369B1 (de) * 1990-12-21 1997-09-17 Merrell Pharmaceuticals Inc. Neue trizyklische Amino- und Nitro Verbindungen mit ACE-hemmenden Eigenschaften
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
CA2119019A1 (en) * 1991-09-16 1993-04-01 Harry R. Davis Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation
AU668707B2 (en) * 1992-02-14 1996-05-16 Merrell Pharmaceuticals Inc. Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ACE
DK0640086T3 (da) * 1992-05-15 1999-12-06 Merrell Pharma Inc Mercaptoacetylamido-pyridazo[1,2-a][1,2]diazepin-derivateranvendelige som enkephalinase- og ACE-inhibitorer
RU2124503C1 (ru) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
CA2184696A1 (en) 1995-09-28
EP0751783B1 (de) 2000-02-02
GR3033117T3 (en) 2000-08-31
US5602122A (en) 1997-02-11
NO963987D0 (no) 1996-09-23
FI963783A0 (fi) 1996-09-23
WO1995025532A1 (en) 1995-09-28
US5624921A (en) 1997-04-29
DK0751783T3 (da) 2000-06-26
FI963783A7 (fi) 1996-09-23
HUT75160A (en) 1997-04-28
CA2184696C (en) 2001-01-02
DE69514912D1 (de) 2000-03-09
ZA952284B (en) 1996-01-09
DE69514912T2 (de) 2000-10-05
IL113076A0 (en) 1995-06-29
CN1144487A (zh) 1997-03-05
AU1972495A (en) 1995-10-09
IL113076A (en) 2000-09-28
NZ282568A (en) 1997-07-27
PT751783E (pt) 2000-05-31
EP0751783A1 (de) 1997-01-08
ATE189392T1 (de) 2000-02-15
AU698320B2 (en) 1998-10-29
JPH09510476A (ja) 1997-10-21
ES2141923T3 (es) 2000-04-01
FI963783L (fi) 1996-09-23

Similar Documents

Publication Publication Date Title
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
NO20056021L (no) Anvendelse av CS-866 til fremstilling av et medikament
FI972922L (fi) Tarkkaamattomuuden ja yliaktiivisuuden hoito
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
EP0909561A3 (de) Verwendung der Reboxetin zur Behandlung der Aufmerksamkeitsmangel/Hyperaktivität Störung
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
IT1305069B1 (it) Polsino per la prevenzione e il trattamento della sindrome del tunnelcarpale e metodo per la sua applicazione
PT804229E (pt) Utilizacao de amlodipina de um dos seus sais ou defelodipina em combinacao com um inibidor da en zima de conversao da angiotensina (ace) para no fabrico de um medicamento destinado ao tratamento da insuficiencia cardiaca congestiva nao isquemica
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
NO963987L (no) Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske aminoacetylmercaptoderivater
DK0751775T3 (da) Hypocholesterolæmiske, antiatherosclerotiske og hypotriglyceridæmiske mercaptoacetylamidderivater
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
NO963988L (no) Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske mercaptoacetylamidderivater
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
PT980251E (pt) Factor de tecido para influenciar a formacao de vasos sanguineos
GB9616549D0 (en) Therapeutic product and its use
UA30556A (uk) Спосіб модуляції гоєння ран
UA31270A (uk) Спосіб формування товстокишкового анастомозу
EA199800698A1 (ru) Способ лечения и фармацевтическая композиция

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application